Search for: "JOHNSON v. PFIZER, INC." Results 61 - 80 of 95
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Oct 2008, 10:31 am
" Specifically, "infections triggered safety alerts for the arthritis medicines Enbrel (etanercept), sold by Amgen Inc.; Johnson & Johnson's Remicade (infliximab); and Abbott Laboratories' Humira (adalimumab). [read post]
8 Dec 2007, 11:00 am
(more on the Wahaha v Danone dispute): (China Business Law Blog), What Global Players could learn from Wii v Vii [Nintendo's global new product launch mistakes]: (IPDragon), (China Law Blog), Junk Patents: (China Hearsay),Has your distributor (representative, manufacturer) in China registered your mark? [read post]
22 Feb 2008, 1:30 pm
  The decision in Reidel v. [read post]
21 Apr 2011, 1:36 pm by Bexis
Alpharma USPD, Inc., 887 So.2d 881, 883 (Ala. 2004)) (emphasis added).That’s four.Finally, in Overton v. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over… [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]